Found: 44
Select item for more details and to access through your institution.
Electrocardiogram Abnormalities Suggest Aberrant Cardiac Conduction in Huntington's Disease.
- Published in:
- Movement Disorders Clinical Practice, 2018, v. 5, n. 3, p. 306, doi. 10.1002/mdc3.12596
- By:
- Publication type:
- Article
The Vasopressin 1a Receptor Antagonist SRX246 Reduces Aggressive Behavior in Huntington's Disease.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 10, p. 1561, doi. 10.3390/jpm12101561
- By:
- Publication type:
- Article
Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease Mice.
- Published in:
- Journal of Neuroscience, 2003, v. 23, n. 28, p. 9418, doi. 10.1523/JNEUROSCI.23-28-09418.2003
- By:
- Publication type:
- Article
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients—A Randomized Phase 2 Clinical Trial.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 11, p. 3682, doi. 10.3390/jcm9113682
- By:
- Publication type:
- Article
Linking SNPs to CAG repeat length in Huntington's disease patients.
- Published in:
- Nature Methods, 2008, v. 5, n. 11, p. 951, doi. 10.1038/nmeth.1261
- By:
- Publication type:
- Article
Complexity and Heterogeneity: What Drives the Ever-changing Brain in Huntington's Disease?
- Published in:
- Annals of the New York Academy of Sciences, 2008, v. 1147, p. 196, doi. 10.1196/annals.1427.034
- By:
- Publication type:
- Article
Iron Accumulates in Huntington’s Disease Neurons: Protection by Deferoxamine.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0077023
- By:
- Publication type:
- Article
Thalamocortical synapses of pyramidal cells which project from SmI to MsI cortex in the mouse.
- Published in:
- Journal of Comparative Neurology, 1981, v. 198, n. 1, p. 167, doi. 10.1002/cne.901980114
- By:
- Publication type:
- Article
Thalamocortical synapses involving identified neurons in mouse primary somatosensory cortex: A terminal degeneration and golgi/EM study.
- Published in:
- Journal of Comparative Neurology, 1981, v. 195, n. 2, p. 253, doi. 10.1002/cne.901950206
- By:
- Publication type:
- Article
Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra.
- Published in:
- Journal of Comparative Neurology, 1997, v. 388, n. 2, p. 211, doi. 10.1002/(SICI)1096-9861(19971117)388:2<211::AID-CNE3>3.0.CO;2-4
- By:
- Publication type:
- Article
Light and electron microscopic study of m2 muscarinic acetylcholine receptor in the basal forebrain of the rat.
- Published in:
- Journal of Comparative Neurology, 1995, v. 351, n. 3, p. 339, doi. 10.1002/cne.903510303
- By:
- Publication type:
- Article
Cortical inputs to m2-immunoreactive striatal interneurons in rat and monkey.
- Published in:
- Synapse, 2000, v. 37, n. 4, p. 252, doi. 10.1002/1098-2396(20000915)37:4<252::AID-SYN2>3.0.CO;2-A
- By:
- Publication type:
- Article
Neuroprotective Effects of Synaptic Modulation in Huntington's Disease R6/2 Mice.
- Published in:
- Journal of Neuroscience, 2007, v. 27, n. 47, p. 12908, doi. 10.1523/JNEUROSCI.4318-07.2007
- By:
- Publication type:
- Article
The PTB domain of ShcA couples receptor activation to the cytoskeletal regulator IQGAP1.
- Published in:
- EMBO Journal, 2010, v. 29, n. 5, p. 884, doi. 10.1038/emboj.2009.399
- By:
- Publication type:
- Article
Cytochrome C and caspase-9 expression in Huntington’s disease.
- Published in:
- NeuroMolecular Medicine, 2002, v. 1, n. 3, p. 183, doi. 10.1385/NMM:1:3:183
- By:
- Publication type:
- Article
Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Cerebral cortex and the clinical expression of Huntingtons disease: complexity and heterogeneity.
- Published in:
- Brain: A Journal of Neurology, 2008, v. 131, n. 4, p. 1057, doi. 10.1093/brain/awn025
- By:
- Publication type:
- Article
Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice.
- Published in:
- Journal of Comparative Neurology, 2002, v. 449, n. 3, p. 241, doi. 10.1002/cne.10295
- By:
- Publication type:
- Article
Muscarinic m1 and m2 receptor proteins in local circuit and projection neurons of the primate striatum: Anatomical evidence for cholinergic modulation of glutamatergic prefronto-striatal pathways.
- Published in:
- Journal of Comparative Neurology, 2001, v. 434, n. 4, p. 445, doi. 10.1002/cne.1186
- By:
- Publication type:
- Article
Minocycline is protective in a mouse model of Huntington's disease.
- Published in:
- Annals of Neurology, 2003, v. 54, n. 6, p. 841
- By:
- Publication type:
- Article
Monitoring Reportable Events and Unanticipated Problems: The PHAROS and PREDICT Studies of Huntington Disease.
- Published in:
- IRB: Ethics & Human Research, 2007, v. 29, n. 3, p. 11
- By:
- Publication type:
- Article
The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS.
- Published in:
- Human Molecular Genetics, 2011, v. 20, n. 20, p. 3986, doi. 10.1093/hmg/ddr326
- By:
- Publication type:
- Article
Utility of the Huntington's Disease Prognostic Index Score for a Perimanifest Clinical Trial.
- Published in:
- Movement Disorders, 2022, v. 37, n. 5, p. 1040, doi. 10.1002/mds.28944
- By:
- Publication type:
- Article
Clinical Outcomes and Selection Criteria for Prodromal Huntington's Disease Trials.
- Published in:
- Movement Disorders, 2020, v. 35, n. 12, p. 2193, doi. 10.1002/mds.28222
- By:
- Publication type:
- Article
Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13195-024-01441-8
- By:
- Publication type:
- Article
Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13195-024-01441-8
- By:
- Publication type:
- Article
A natural history study to track brain and spinal cord changes in individuals with Friedreich's ataxia: TRACK-FA study protocol.
- Published in:
- PLoS ONE, 2022, v. 17, n. 11, p. 1, doi. 10.1371/journal.pone.0269649
- By:
- Publication type:
- Article
Thalamocortical and other synapses involving nonspiny multipolar cells of mouse SmI cortex.
- Published in:
- Journal of Comparative Neurology, 1984, v. 229, n. 3, p. 311, doi. 10.1002/cne.902290303
- By:
- Publication type:
- Article
A quantitative study of the thalamocortical and other synapses in layer IV of pyramidal cells projecting from mouse SmI cortex to the caudate-putamen nucleus.
- Published in:
- Journal of Comparative Neurology, 1982, v. 211, n. 3, p. 217, doi. 10.1002/cne.902110302
- By:
- Publication type:
- Article
The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease.
- Published in:
- Molecular Neurodegeneration, 2010, v. 5, p. 26, doi. 10.1186/1750-1326-5-26
- By:
- Publication type:
- Article
EF-P Dependent Pauses Integrate Proximal and Distal Signals during Translation.
- Published in:
- PLoS Genetics, 2014, v. 10, n. 8, p. 1, doi. 10.1371/journal.pgen.1004553
- By:
- Publication type:
- Article
Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models.
- Published in:
- Human Molecular Genetics, 2007, v. 16, n. 11, p. 1293, doi. 10.1093/hmg/ddm078
- By:
- Publication type:
- Article
HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosis.
- Published in:
- Human Molecular Genetics, 2002, v. 11, n. 23, p. 2815, doi. 10.1093/hmg/11.23.2815
- By:
- Publication type:
- Article
Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice.
- Published in:
- Human Molecular Genetics, 2002, v. 11, n. 6, p. 633, doi. 10.1093/hmg/11.6.633
- By:
- Publication type:
- Article
Impaired Cerebrovascular Reactivity in Huntington's Disease.
- Published in:
- Frontiers in Physiology, 2021, v. 12, p. 1, doi. 10.3389/fphys.2021.663898
- By:
- Publication type:
- Article
Huntington aggregates may not predict neuronal death in Huntington's disease.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Cystamine increasesl-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation.
- Published in:
- Journal of Neurochemistry, 2004, v. 91, n. 2, p. 413, doi. 10.1111/j.1471-4159.2004.02726.x
- By:
- Publication type:
- Article
Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice.
- Published in:
- Journal of Neurochemistry, 2003, v. 85, n. 6, p. 1359, doi. 10.1046/j.1471-4159.2003.01706.x
- By:
- Publication type:
- Article
Association of HAP1 Isoforms with a Unique Cytoplasmic Structure.
- Published in:
- Journal of Neurochemistry, 1998, v. 71, n. 5, p. 2178, doi. 10.1046/j.1471-4159.1998.71052178.x
- By:
- Publication type:
- Article
Rho Kinase Pathway Alterations in the Brain and Leukocytes in Huntington's Disease.
- Published in:
- Molecular Neurobiology, 2016, v. 53, n. 4, p. 2132, doi. 10.1007/s12035-015-9147-9
- By:
- Publication type:
- Article
A tale of two factors: What determines the rate of progression in Huntington's disease? A longitudinal MRI study.
- Published in:
- Movement Disorders, 2011, v. 26, n. 9, p. 1691, doi. 10.1002/mds.23762
- By:
- Publication type:
- Article
Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures.
- Published in:
- Movement Disorders, 2006, v. 21, n. 9, p. 1317, doi. 10.1002/mds.20979
- By:
- Publication type:
- Article
A systems-level 'misunderstanding': the plasma metabolome in Huntington's disease.
- Published in:
- Annals of Clinical & Translational Neurology, 2015, v. 2, n. 7, p. 756, doi. 10.1002/acn3.214
- By:
- Publication type:
- Article